Clinical TrialsSearch results
Number of results: 67288
Not yet recruiting
- Trial of the efficacy of food ingredients on knee joint function (SWE-2024-01-HBLOCO)
- Not applicable
- Suntory Wellness Limited
- 2024-06-05
Other
- A verification study on the effects of a beverage containing the probiotic Lactococcus 11/19-B1 on nasal mucociliary clearance function and immune activation.
- Healthy adults
- Kyodo Milk Industry Co., Ltd.
- 2024-06-05
Other
- Development of a prediction model of infectious disease among patients with undiagnosed fever: A single-hospital-based retrospective study
- fever of unknown origin
- Department of General Medicine, Saga University Hospital, Japan
- 2024-06-05
Other
- Dynamic variation of tibiofemoral compression force during total knee arthroplasty: Implications for soft tissue balance and functional outcomes
- Knee osteoarthritis
- Osaka Medical and Pharmaceutical University
- 2024-06-05
Recruiting
- A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD-L1 high NSCLC
- Non-small-cell lung cancer
- Ishibashi Hideyasu
- 2024-06-04
Recruiting
- Epigenetic genetic analysis of lens epithelium and retinal proliferative membrane in ocular diseases.
- Cataract, ischemic retinal disease (including diabetic retinopathy, retinal vein occlusion, retinopathy of prematurity)
- University of Fukui
- 2024-06-04
Recruiting
- General Drug Use-Results Survey of COMLEX OTIC SOLUTION 1.5%
- Otitis externa, Chronic otitis media, and Acute otitis media
- CEOLIA Pharma.Co.Ltd Pharmacovigilance Office
- 2024-06-04
Recruiting
- JBCRG-M10 (INDUCE trial)
- PD-L1-positive, hormone receptor-negative, HER2-negative inoperable or recurrent breast cancer
- Ozaki Yukinori
- 2024-06-04
Recruiting
- Stent-less Treatment Strategy for acute coronary syndrome
- Acute coronary syndrome
- Hibi Kiyoshi
- 2024-06-04
Not yet recruiting
- A study on the immune response, safety and the occurrence of RSV-associated respiratory tract illness after administration of RSV OA vaccine in adults 60 years and older.
- Respiratory Syncytial Virus Infections
- Okawa Yasutoshi
- 2024-06-04